T 2024/18 (Missing statement of grounds) of 12.03.2019
- European Case Law Identifier
- ECLI:EP:BA:2019:T202418.20190312
- Date of decision
- 12 March 2019
- Case number
- T 2024/18
- Online on
- 22 March 2019
- Petition for review of
- -
- Application number
- 04703158.8
- IPC class
- A61K 9/14
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- PROCESS FOR MODIFYING DRUG CRYSTAL FORMATION OF MYCOPHENOLATE SODIUM SALT
- Applicant name
- Novartis AG
Novartis Pharma GmbH - Opponent name
- Teva Pharmaceutical Industries Ltd.
Accord Healthcare Ltd - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 108European Patent Convention R 99(2)European Patent Convention R 101(1)
- Keywords
- Admissibility of appeal - missing statement of grounds
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is rejected as inadmissible.